Mangalam Drugs And Organics Limited Share Price & Company Info
- Market cap
- ₹45.28 Cras reported by NSE
- 52-week high
- ₹68.9029-OCT-2025
- 52-week low
- ₹22.8029-DEC-2025
- Face value
- ₹10.00
- Shares issued
- 1,58,28,248
- Volume
- 20,129₹0.06 Cr traded
- Delivery
- 86.51%of traded quantity
- Price band
- 10%₹26.30 – ₹32.14 on 2026-11-02
- Annual volatility
- 59.99%NSE, from daily returns
- Series
- EQrolling settlement
- BSE group
- Bscrip code 532637
- ISIN
- INE584F01014
- Listed on NSE
- 23-May-2005
About Mangalam Drugs And Organics Limited
Mangalam Drugs And Organics Limited is listed on the National Stock Exchange of India under the symbol MANGALAM in the EQ series. NSE classifies it under the basic industry Pharmaceuticals, part of the Healthcare sector. Its shares were listed on NSE on 23-May-2005. Each share has a face value of ₹10.00.
In the end-of-day data for 16 November 2026 the stock closed at ₹28.60, down 2.16% on the day. NSE puts the company's market capitalisation at about ₹45.28 crore, which puts it among the smallest listed companies in India. Over the past 52 weeks it has traded between ₹22.80 and ₹68.90, so the last price is 25.4% above the low and 58.5% below the high.
20,129 shares changed hands that day, and 86.51% of them were taken as delivery rather than squared off intraday. A high delivery share means most of the day's buyers chose to hold the shares; a low one usually means the volume was mostly short-term trading.
EQ is the normal equity series: shares settle on the usual T+1 cycle and intraday trading is allowed.
NSE currently lists a regulatory note for this stock: “LT ASM-1 | EPS based on prev. 4 trailing Qtrs. in the scrip is zero”. Notes like these come from the exchange's surveillance and disclosure checks and can mean higher margins, trade-for-trade settlement or limits on trading. Check the NSE quote page for the current position before trading.
NSE puts the stock's annualised volatility at 59.99%. That is well above the level of large, established companies, so double-digit swings within a month are common.
Because the share trades below ₹30, it also appears in our list of penny stocks under ₹30, which explains the extra risks that come with low-priced shares.
Mangalam Drugs And Organics Limited quarterly results
In the quarter ended June 2026 (un-audited), Mangalam Drugs And Organics Limited reported total income of ₹57.23 crore and a net loss of ₹7.55 crore, or ₹-4.77 per share.
Compared with the previous quarter (March 2026), income fell 15.1%.
Mangalam Drugs And Organics Limited was profitable in 0 of the 4 quarters shown below, and made a loss in all of them. Figures are as filed with NSE, in ₹ crore.
| Quarter ended | Total income | Profit before tax | Net profit | EPS | Status |
|---|---|---|---|---|---|
| June 2026 | 57.23 | -6.66 | -7.55 | -4.77 | Un-Audited |
| March 2026 | 67.38 | -12.91 | -13.06 | -8.25 | Audited |
| December 2025 | 58.60 | -9.78 | -9.78 | -6.18 | Un-Audited |
| September 2025 | 49.57 | -12.37 | -7.25 | -4.58 | Un-Audited |
Mangalam Drugs And Organics Limited shareholding pattern
At the end of September 2026, promoters and the promoter group held 35.65% of Mangalam Drugs And Organics Limited, with the public holding 64.35%. That is down 14.65 percentage points from 50.30% in December 2024.
A falling promoter stake is one of the things investors watch most closely in small companies, because it can signal insiders selling. The quarterly shareholding filings on NSE show who bought or sold.
| Quarter ended | Promoter & Promoter Group (%) | Public (%) |
|---|---|---|
| September 2026 | 35.65 | 64.35 |
| June 2026 | 35.65 | 64.35 |
| March 2026 | 35.65 | 64.35 |
| December 2025 | 35.64 | 64.36 |
| September 2025 | 50.30 | 49.70 |
| June 2025 | 50.30 | 49.70 |
| March 2025 | 50.30 | 49.70 |
| December 2024 | 50.30 | 49.70 |
Mangalam Drugs And Organics Limited share price performance
Over the past year the Mangalam Drugs And Organics Limited share price has lost 56.66%, against a fall of 10.92% for the NIFTY 50, so it has underperformed that index by 45.74 percentage points.
Across the 7 periods in the table, the stock beat the NIFTY 50 in 2. Past returns describe what happened; they do not predict what comes next.
| Period | MANGALAM | NIFTY 50 |
|---|---|---|
| 1 month | -6.99% | +1.91% |
| 3 months | +5.62% | -5.20% |
| 6 months | -3.02% | -3.94% |
| 1 year | -56.66% | -10.92% |
| 2 years | -74.37% | -5.29% |
| 3 years | -71.68% | +20.44% |
| 5 years | -78.70% | +30.45% |
Mangalam Drugs And Organics Limited vs industry peers
NSE compares Mangalam Drugs And Organics Limited with 6 other listed companies in Pharmaceuticals. By market capitalisation it ranks 4 of 7.
| Company | Market cap | Price (₹) | P/E | Promoter % | Qtr income | Qtr net profit |
|---|---|---|---|---|---|---|
| SUNLOC | 63.12 | 61.55 | — | 0.00 | — | — |
| BIOFILCHEM | 47.18 | 28.99 | 96.41 | 46.79 | 12.41 | 0.11 |
| VIVIMEDLAB | 45.85 | 5.53 | — | 0.00 | — | — |
| MANGALAM | 45.25 | 28.59 | — | 35.65 | 57.23 | -7.55 |
| NATCO-RE | 44.27 | 25.95 | — | 0.00 | — | — |
| MEDIORG | 39.43 | 26.50 | — | 54.89 | — | — |
| SUNREST | 33.69 | 39.25 | 8.18 | 53.50 | — | — |
Mangalam Drugs And Organics Limited announcements, board meetings and corporate actions
Latest announcements
The most recent filings Mangalam Drugs And Organics Limited has made with NSE, newest first:
- 16-Oct-2026 · Fraud/Default/Arrest: Mangalam Drugs And Organics Limited has informed the Exchange about Fraud/Default/Arrest (PDF)
- 07-Oct-2026 · Certificate under SEBI (Depositories and Participants) Regulations, 2018: Mangalam Drugs And Organics Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 (PDF)
- 03-Oct-2026 · Copy of Newspaper Publication: Mangalam Drugs And Organics Limited has informed the Exchange about Copy of Newspaper Publication (PDF)
- 01-Oct-2026 · Shareholders meeting: Mangalam Drugs And Organics Limited has informed the Exchange regarding Notice of Postal Ballot (PDF)
- 25-Sep-2026 · Trading Window: Mangalam Drugs And Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (PDF)
- 24-Sep-2026 · Change in Management: Mangalam Drugs And Organics Limited has informed the Exchange about change in Management (PDF)
- 24-Sep-2026 · Retirement: Mangalam Drugs And Organics Limited has informed the Exchange about Retirement (PDF)
- 24-Sep-2026 · Appointment: Mangalam Drugs And Organics Limited has informed the Exchange regarding Appointment of S.N Nanda & Co. (FRN: 000685N) as Other of the company w.e.f. September 23, 2026. (PDF)
Board meetings
- 05-Nov-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended September 30, 2026 and other business matters
- 12-Aug-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
- 14-May-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended March 31, 2026 and other business matters
- 26-Mar-2026 · Other business matters: To consider other business matters
- 06-Feb-2026 · Other business matters: To consider other business matters
Corporate actions
The corporate actions on record include 1 dividend. The ex-date is the first day the shares trade without the entitlement.
- Annual General Meeting · ex-date 17-Sep-2018 · book closure 19-Sep-2018 to 25-Sep-2018
- Interim Dividend Re 0.50 Per Share · ex-date 21-Dec-2017 · record date 22-Dec-2017
- Annual General Meeting · ex-date 18-Sep-2017 · book closure 20-Sep-2017 to 26-Sep-2017
- Annual General Meeting (Book Closure Dates Revised) · ex-date 22-Sep-2016 · book closure 24-Sep-2016 to 30-Sep-2016
- Annual General Meeting · ex-date 26-Aug-2015 · book closure 28-Aug-2015 to 03-Sep-2015
- Annual General Meeting · ex-date 18-Sep-2014 · book closure 22-Sep-2014 to 29-Sep-2014
- Annual General Meeting · ex-date 17-Sep-2013 · book closure 19-Sep-2013 to 26-Sep-2013
- Annual General Meeting · ex-date 17-Sep-2012 · book closure 20-Sep-2012 to 27-Sep-2012
- Annual General Meeting · ex-date 20-Sep-2011 · book closure 22-Sep-2011 to 29-Sep-2011
- Annual General Meeting · ex-date 21-Sep-2010 · book closure 23-Sep-2010 to 30-Sep-2010
Risk notice: low-priced and small-company shares can be illiquid, volatile and subject to manipulation, and shareholders can lose their entire investment. This page is a factual summary, not a recommendation to buy or sell Mangalam Drugs And Organics Limited.
Where to find Mangalam Drugs And Organics Limited's financials
Direct downloads from NSE:
- Annual report 2025-26 (PDF, 9.79 MB)
- Annual report 2024-25 (PDF, 4.04 MB)
- Annual report 2024-25 (PDF, 3.01 MB)
- Annual report 2023-24 (PDF)
- Annual report 2022-23 (ZIP)
- Annual report 2021-22 (ZIP)
For full financial statements, shareholding detail and every company announcement, go to the source:
- NSE quote pageOfficial price, price band, surveillance status, shareholding pattern and corporate actions.
- Annual reports (NSE)Search “MANGALAM” to download Mangalam Drugs And Organics Limited's annual reports as filed with the exchange.
- Announcements and results (NSE)Search “MANGALAM” for quarterly results, board meetings and other company filings.
- BSE quote page (532637)BSE price, filings, results and shareholding for the same company.
- ScreenerTen years of profit and loss, balance sheet, cash flow and key ratios.
- TradingView chartInteractive price chart with technical indicators.
- Google FinanceQuick price overview and recent news coverage.
- Yahoo FinanceHistorical prices you can download, plus summary statistics.
Other Pharmaceuticals stocks on MCX Trends
- Syncom Formulations (India) Limited (SYNCOMF · ₹21.19)
- Anlon Healthcare Limited (AHCL · ₹25.77)
- Sigachi Industries Limited (SIGACHI · ₹28.16)
- Vineet Laboratories Limited (VINEETLAB · ₹37.52)
- Ambalal Sarabhai Enterprises Limited (AMBALALSA · ₹38.62)
- Medico Remedies Limited (MEDICO · ₹18.31)
- Nectar Lifesciences Limited (NECLIFE · ₹10.31)
- Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM · ₹30.67)
Frequently asked questions
What is the Mangalam Drugs And Organics Limited share price?
Mangalam Drugs And Organics Limited (NSE: MANGALAM) closed at ₹28.60 in the end-of-day data for 16 November 2026. For a live price, use the NSE quote page or your broker, because this page is updated from end-of-day files.
Which sector does Mangalam Drugs And Organics Limited belong to?
NSE classifies Mangalam Drugs And Organics Limited under Pharmaceuticals, in the Healthcare sector.
What is the 52-week high and low of MANGALAM?
The 52-week high is ₹68.90 (29-OCT-2025) and the 52-week low is ₹22.80 (29-DEC-2025), according to NSE.
Is Mangalam Drugs And Organics Limited a penny stock?
At ₹28.60 the share trades below ₹30, so it appears on our list of penny stocks under ₹30. A low share price on its own says nothing about whether a company is cheap or expensive; market capitalisation, debt, profits and exchange surveillance status matter far more.
What is the promoter holding in Mangalam Drugs And Organics Limited?
Promoters and the promoter group held 35.65% of Mangalam Drugs And Organics Limited at the end of September 2026, according to the shareholding pattern filed with NSE.
What were Mangalam Drugs And Organics Limited's latest quarterly results?
For the quarter ended June 2026, Mangalam Drugs And Organics Limited reported total income of ₹57.23 crore and a net loss of ₹7.55 crore (EPS ₹-4.77).
Where can I find Mangalam Drugs And Organics Limited's annual report and financial results?
Annual reports, quarterly results and other filings are published on the NSE corporate filings pages (search for MANGALAM) and on BSE. Screener also lays out several years of financial statements in one place. Links to all of these are above.